1. Home
  2. TECX vs HIO Comparison

TECX vs HIO Comparison

Compare TECX & HIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$33.99

Market Cap

393.0M

Sector

N/A

ML Signal

N/A

Logo Western Asset High Income Opportunity Fund Inc.

HIO

Western Asset High Income Opportunity Fund Inc.

N/A

Current Price

$3.67

Market Cap

364.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TECX
HIO
Founded
2019
1993
Country
United States
United States
Employees
51
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
393.0M
364.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TECX
HIO
Price
$33.99
$3.67
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$80.40
N/A
AVG Volume (30 Days)
552.9K
366.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
10.33%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.70
$3.36
52 Week High
$35.99
$4.13

Technical Indicators

Market Signals
Indicator
TECX
HIO
Relative Strength Index (RSI) 75.47 33.37
Support Level $16.83 N/A
Resistance Level N/A $3.91
Average True Range (ATR) 2.45 0.03
MACD 1.27 -0.01
Stochastic Oscillator 87.37 22.73

Price Performance

Historical Comparison
TECX
HIO

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About HIO Western Asset High Income Opportunity Fund Inc.

Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.

Share on Social Networks: